Opus Genetics, Inc.
Phentolamine
presbyopia
Countdown
57days
FDA decision · Sep 1, 2026
What's at stake
The FDA's approval decision on Phentolamine for presbyopia is due Sep 1, 2026. A green light opens the market; a complete response letter (CRL) usually sinks the stock.
Primary source
· SEC 8-K
verified 13h ago
“PDUFA date for Phentolamine sNDA Sept 2026”